We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $248M invested in Rigel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $115K | Put options by funds: $35K

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

26% more capital invested

Capital invested by funds: $197M → $248M (+$50.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 122 → 121 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
49
Reduced
31
Closed
10
Calls
$115K
Puts
$35K
Net Calls
+$80K
Net Calls Change
+$61K

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
+$3.34M
2
BFA
BlackRock Fund Advisors
California
+$3.33M
3
PC
Paulson & Co
New York
+$1.6M
4
Millennium Management
Millennium Management
New York
+$1.12M
5
ACP
Acuta Capital Partners
California
+$776K

Top Sellers

1
BC
Broadfin Capital
New York
-$6.06M
2
TC
TFS Capital
Pennsylvania
-$843K
3
UBS AM
UBS AM
Illinois
-$634K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$619K
5
MOACM
Mutual of America Capital Management
New York
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$2.2M – – –
TCIM
27
TIAA CREF Investment Management
New York
$2.1M +$186K +6,130 +10%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.99M +$237K +7,814 +14%
State of New Jersey Common Pension Fund D
29
State of New Jersey Common Pension Fund D
New Jersey
$1.67M – – –
PC
30
Paulson & Co
New York
$1.6M +$1.6M +52,870 New
Renaissance Technologies
31
Renaissance Technologies
New York
$1.51M +$306K +10,100 +25%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.4M +$177K +5,822 +14%
ACP
33
Acuta Capital Partners
California
$1.38M +$776K +25,606 +128%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.29M -$5.67K -187 -0.4%
BA
35
BlackRock Advisors
Delaware
$1.25M -$177K -5,845 -12%
BIM
36
BlackRock Investment Management
Delaware
$970K +$9.7K +320 +1%
SIM
37
Spark Investment Management
New York
$965K +$18.8K +620 +2%
BIM
38
Bogle Investment Management
Massachusetts
$929K -$127K -4,181 -12%
WMSA
39
Weiss Multi-Strategy Advisers
New York
$924K +$3.03K +100 +0.3%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$867K -$85.5K -2,820 -9%
TI
41
Turner Investments
Pennsylvania
$864K – – –
NSEDCP
42
NJ State Employees Deferred Compensation Plan
New Jersey
$773K – – –
TI
43
Telemetry Investments
New York
$758K – – –
Morgan Stanley
44
Morgan Stanley
New York
$690K +$268K +8,828 +63%
RFC
45
Russell Frank Company
Washington
$677K +$14.9K +492 +2%
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$641K -$32.7K -1,080 -5%
Charles Schwab
47
Charles Schwab
California
$611K – – –
BCM
48
Bridgeway Capital Management
Texas
$592K -$111K -3,650 -16%
SO
49
STRS Ohio
Ohio
$590K +$175K +5,770 +42%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$495K +$8.73K +288 +2%
1
2
3 4 5

RIGL Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2015, worth a combined $248M — up 26% from $197M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 49 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $3.34M. The largest seller was Broadfin Capital, cutting an estimated $6.06M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2015, down from 122 in Q3 2015.
  • Funds reported $248M of Rigel Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q4 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q4 2015 was Rock Springs Capital Management, an estimated $3.34M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2015 was Broadfin Capital, an estimated $6.06M sold.

Based on aggregated 13F filings for Q4 2015.